MENU
+Compare
HSCS
Stock ticker: NASDAQ
AS OF
Jun 5 closing price
Price
$3.59
Change
-$0.19 (-5.03%)
Capitalization
7.66M

HSCS HeartSciences Inc Forecast, Technical & Fundamental Analysis

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease... Show more

HSCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HSCS with price predictions
Jun 05, 2025

HSCS's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for HSCS moved out of overbought territory on May 21, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HSCS as a result. In of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HSCS turned negative on May 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSCS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HSCS broke above its upper Bollinger Band on May 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HSCS advanced for three days, in of 118 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 16 cases where HSCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.843) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (126.582) is also within normal values, averaging (42.393).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HSCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HSCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HSCS is expected to report earnings to rise 16.73% to -300 cents per share on July 17

HeartSciences Inc HSCS Stock Earnings Reports
Q2'24
Est.
$-3.00
Q1'25
Beat
by $0.43
Q3'24
Beat
by $1.36
Q1'24
Beat
by $0.03
Q4'23
Missed
by $0.04
The last earnings report on March 13 showed earnings per share of -256 cents, beating the estimate of -300 cents. With 96.42K shares outstanding, the current market capitalization sits at 7.66M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
550 Reserve Street
Phone
+1 737 414-9213
Employees
12
Web
https://www.heartsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT19.720.16
+0.82%
Summit Therapeutics
ZD32.820.13
+0.40%
Ziff Davis
EVGN1.11-0.01
-0.45%
Evogene Ltd.
ISTR18.65-0.15
-0.80%
Investar Holding Corp
GYRE7.94-0.64
-7.46%
Gyre Therapeutics

HSCS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HSCS has been loosely correlated with RSLS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HSCS jumps, then RSLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSCS
1D Price
Change %
HSCS100%
-5.29%
RSLS - HSCS
35%
Loosely correlated
-12.01%
HSDT - HSCS
32%
Poorly correlated
-65.75%
BNGO - HSCS
22%
Poorly correlated
-0.54%
PSNL - HSCS
22%
Poorly correlated
-1.75%
MBOT - HSCS
21%
Poorly correlated
-2.90%
More